R&D Sponsored AI can give drug hunters more answers. The real advantage is... The most useful question is not if AI can make drug discovery faster: it is whether it can help scientists learn quicker and make better decisions.
Sales & Marketing Media Partner Why BIO-Europe 2026 matters: The evolution of strategic biop... 2026 marks a significant evolution for BIO-Europe.
News Sandoz adds 10 biosimilars through $322m Henlius deal Sandoz is set to add up to 10 new biosimilar assets to its portfolio under a new collaboration deal with China’s Shanghai Henlius Biotech.
Oncology Sponsored Establishing ctDNA as a validated primary surrogate endpoint Circulating tumour DNA (ctDNA) has emerged as a promising primary surrogate endpoint in solid tumour oncology.
Oncology EGFR-mutant lung cancer: Cracking the drug resistance code Targeted therapies have transformed the treatment landscape for non-small cell lung cancer (NSCLC) over the past decade.
R&D Go north: Life sciences excellence shines bright in Sweden Gothenburg is Sweden's fastest-growing and second largest city region and one of Europe's leading innovation regions.
News Isomorphic Labs raises $5bn in massive third round In yet another sign of the appetite for AI companies among investors, Isomorphic Labs has raised a whopping $5bn in a Series C financing.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.